1.47
Rani Therapeutics Holdings Inc (RANI) 最新ニュース
Rani Therapeutics’ (RANI) Buy Rating Reiterated at Canaccord Genuity Group - Defense World
Canaccord Genuity Group Reiterates Buy Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat
Power to the People: How Individual Investors Shape Rani Therapeutics - Smartphone Magazine
Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week - Yahoo Finance
RANI Shares Experience Surge in Value - Knox Daily
Janney Montgomery Scott LLC Buys New Position in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Rani Therapeutics (NASDAQ:RANI) Given Buy Rating at HC Wainwright - MarketBeat
Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World
Analyzing PSQ Holdings Inc (PSQH) After Recent Trading Activity - Knox Daily
Rani Therapeutics’ (RANI) Buy Rating Reiterated at HC Wainwright - Defense World
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable
Rani Therapeutics (NASDAQ:RANI) Shares Up 0.7%Time to Buy? - MarketBeat
Rani Therapeutics (NASDAQ:RANI) Receives “Buy” Rating from HC Wainwright - Armenian Reporter
Was there any good news for Rani Therapeutics Holdings Inc (RANI) stock in the last session? - US Post News
Is Rani Therapeutics Holdings (NASDAQ:RANI) Using Too Much Debt? - Simply Wall St
Market cap of Tantech Holdings Ltd [TANH] reaches 1.11M – now what? - The DBT News
Rani Therapeutics Holdings Inc (RANI Stock: A Sea of Opportunity - The InvestChronicle
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Rani Therapeutics Discloses Progress in Oral Obesity Treatment; Shares Surge Premarket - Marketscreener.com
12 Health Care Stocks Moving In Thursday's Pre-Market SessionInvivyd (NASDAQ:IVVD), (AVGR) - Benzinga
Rani Therapeutics reports positive obesity treatment study - MSN
Rani Therapeutics reports positive obesity treatment study By Investing.com - Investing.com South Africa
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery Of Semaglutide Via Ranipill HC - Marketscreener.com
Rani Therapeutics Announces Preclinical Data Demonstrating - GlobeNewswire
Oral Wegovy Alternative Shows Breakthrough Results: Rani's Pill Matches Injectable Efficacy - StockTitan
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
A company insider recently sold 72,842 shares of Luminar Technologies Inc [LAZR]. Should You Sale? - Knox Daily
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus PT from Brokerages - MarketBeat
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus Target Price from Analysts - Defense World
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average Target Price from Brokerages - MarketBeat
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Purchased by Geode Capital Management LLC - Defense World
Rani Therapeutics stock hits 52-week low at $1.29 - Investing.com India
Rani Therapeutics stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Acquired by Stifel Financial Corp - Defense World
Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $11.71 - Defense World
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average PT from Brokerages - MarketBeat
Rani Therapeutics stock hits 52-week low at $1.32 - Investing.com
Insider Buying: Kate Mckinley Acquires Shares in Rani Therapeuti - GuruFocus.com
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Insider Kate Mckinley Acquires 17,960 Shares - MarketBeat
Rani Therapeutics stock hits 52-week low at $1.85 By Investing.com - Investing.com Nigeria
Rani Therapeutics stock hits 52-week low at $1.85 - Investing.com India
CEO Talat Imran Acquires Additional Shares of Rani Therapeutics Holdings Inc (RANI) - GuruFocus.com
Rani Therapeutics stock hits 52-week low at $1.94 By Investing.com - Investing.com Nigeria
大文字化:
|
ボリューム (24 時間):